By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
News for IndiaNews for IndiaNews for India
  • Home
  • Posts
  • Search Page
  • About us
Reading: Top 2 stocks to buy or sell for short-term: Cyient, Max Healthcare by Nagaraj Shetti – Check stop loss, targets | Stock Market News
Share
Font ResizerAa
News for IndiaNews for India
Font ResizerAa
  • Economics
  • Business
  • Home
  • Categories
    • Business
    • Economics
  • About us
  • Sitemap
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
News for India > Business > Top 2 stocks to buy or sell for short-term: Cyient, Max Healthcare by Nagaraj Shetti – Check stop loss, targets | Stock Market News
Business

Top 2 stocks to buy or sell for short-term: Cyient, Max Healthcare by Nagaraj Shetti – Check stop loss, targets | Stock Market News

Last updated: September 30, 2026 5:26 pm
2 hours ago
Share
SHARE


Contents
Market Views – Nagaraj Shetti, Senior Technical Research Analyst of HDFC SecuritiesStocks to buyBuy Cyient at ₹1,098; Target at ₹1,185; Stoploss at ₹1,050; Timeframe 2-3 weeksSell Max Healthcare Institute at 925; Target at ₹870; Stoploss at ₹955; Timeframe 2-3 weeks

Stock market today: Indian equity benchmarks recorded their steepest monthly decline since March, while the rupee and benchmark bond also weakened as foreign investors moved away from riskier assets. Rising crude oil prices kept inflation concerns elevated, while interest-rate hikes by major global central banks added to pressure on emerging-market assets.

The US Federal Reserve raised its key policy rate in September, alongside rate hikes by central banks in Australia, Europe and Japan. Higher US interest rates typically make the dollar and US bonds more attractive, putting pressure on emerging-market equities and currencies.

On Wednesday, 30 September, the Nifty 50 and Sensex ended marginally lower, declining 0.42% and 0.07%, respectively.

The Nifty 50 declined 6.1% in September to 22,620.45, while the BSE Sensex fell 5.8% to 72,480.29. It was the second consecutive monthly decline for both benchmarks.

Analysts expect the downside for the benchmarks to remain relatively limited following the recent sell-off, but said any recovery could face resistance from persistent Middle East risks. They added that the sustainability of a rebound would largely depend on an improvement in corporate earnings.

Market Views – Nagaraj Shetti, Senior Technical Research Analyst of HDFC Securities

The downside momentum continued in the market amid volatility on Wednesday, and Nifty 50 closed the day lower by 95 points. A small negative candle was formed on the daily chart with long upper shadow.

Technically, this market action signals a lack of strength to sustain the highs. Immediate resistance around 22,800 weighed heavily on the bulls and led to a sharp reversalof morning gains on Wednesday.

The underlying trend of the Nifty 50 remains negative. A weakness below 22,500 could trigger a further decline to the 22,200-22,100 levels in the near term. Any bounce back could find key resistance around the 22,800 levels.

Stocks to buy

Buy Cyient at ₹1,098; Target at ₹1,185; Stoploss at ₹1,050; Timeframe 2-3 weeks

The range-bound action of the last month has resulted in an upside breakout on Wednesday, and the stock price closed higher. Bullish patterns like higher tops and bottoms are intact, and the stock price is attempting to move higher after the higher bottom formation. Volume and RSI patterns indicate more upside in the near term.

Sell Max Healthcare Institute at 925; Target at ₹870; Stoploss at ₹955; Timeframe 2-3 weeks

The healthcare stock has been in a downtrend over the last couple of months. We observe bearish patterns, such as lower tops and bottoms, over the period. Currently, placed at the edge of a decisive breakdown of an important support of ₹910 levels (previous swing lows). A rise in volume is observed during a breakdown in the stock price, and the daily RSI shows a bearish signal.

Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.



Source link

You Might Also Like

Nifty H1FY27 Review: Top gainers and losers | Can H2FY27 deliver better returns? | Stock Market News

Access Denied

Access Denied

Dividend income at risk? 8 stocks with inconsistent dividend payout: Indian Oil, Sanofi India, UTI AMC, and more | Stock Market News

Access Denied

TAGGED:Buy or sellCyientIndian equity benchmarksmax healthcareNagaraj ShettiNifty 50rising crude oil pricessensexstocks to buy
Share This Article
Facebook Twitter Email Print
Previous Article Stocks making the biggest moves premarket: Robinhood, Boeing, Moderna & more
Next Article Access Denied
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

News for IndiaNews for India
© Wealth Wave Designed by Preet Patel. All Rights Reserved.
  • BUSINESS